Prof. Marion Schneider



Academic Degree(s)





Current Position

  • Professor (C3) Experimental Anesthesiology (University Ulm), Germany


Professional Experience

  • 1981 – 83 Postdoctoral fellowship at the Dept. Internal Medicine (Univ.Tübingen) “T cell-deficiencies“
  • 1985 Fellowship at the Institute Pasteur in Paris: “HIV1 susceptibility of AML blasts” (Montagnier/ Chermann/Barré).
  • 1988 – 1997 Lecturer in Theoretical and Practical Immunology (Dept. Microbiology, Univ.Tübingen and Univ. Düsseldorf, Germany)
  • 1989 -97 Head of the Immunology Laboratory at the Institute of Hematostasis and Transfusion Medicine (University of Düsseldorf).


Education & Training

  • 1981 Dr. rer. nat. Rheinische Friedrichs Wilhelms Universität Bonn
  • 1988 Priv. Doz. Eberhard Karls Universität Tübingen
  • 1998 Prof. (C3) Albert Einstein Universität Ulm



  • Konrad Adenauer Award for Investigations in Starch Metabolism Bonn , Germany (1981)
  • Artemis Fellowship Award, Athens,  Greece (1997)
  • Nezelof Award of the International Histiocyte Society (1998)
  • Queen Silvia Award of The Histiocyte Society for protein chip development (2004)
  • A.E. Baue Research Award (2nd) , Munich (2010)


Research Grants

  • Cavity Enhanced Microarray as an Ultra-sensitive Tool to aid Sepsis Diagnosis, EU FP7. 2014 -2017
  • Early detection of adverse effects on immunotherapeutic drug substances using innovative highly complex organotypic co-culture systems combined with systems biology based pathway analysis – HuCoCSys BMBF 02.2008-02.2012, Col.
  • Diamant-basierte Biochips zur Detektion der P2X7-Aktivität  MSTII  Landesstiftung BW 2008 – 2012.
  • Biomarker Analysis in Hemophagocytic Diseases Histiocytosis Association of America. 05. 2009 – 04. 2010, PI.
  • QuAGSiC Quantitative Analysis of Genes in Single Cells EU  FP6 07.2006 – 05-2008, Col.
  • EU  LSH-2003-1. 1.0-1  GenOSept Genetics of sepsis in Europe  EU  FP6 03. 2005 – 02. 2008, Col.
  • NGFN-II  Inflammation and pathogenesis of Type 2 Diabetes, cardiovascular disease and atherosclerosis within the National Genome Research Project 01GS0423 – BMBF 09.2004– 08.2007 Col.
  • Novel photoconvertable fluorescent proteins to trace hemophagocytes in whole blood. A study in European patients. Histiocytosis Association of America. 05. 2005 – 04. 2007, PI


Selected Publication

  • Sander, P, Walther, P,  Moepps, M, Hinz, M, Mostafa, H, Schaefer, P, Pala, A,  Wirtz, C.R,  Georgieff, M, Schneider, EM.  Mitophagy-Related Cell Death Mediated by Vacquinol-1 and TRPM7 Blockade in Glioblastoma IV. In: for "Glioma - Contemporary Diagnostic and Therapeutic Approaches" published by InTechOpen; in press.
  • Waqas, SF, Hassnain, Hoang, AC, Lin, Y-T, Ampem, G., Azegrouz, H, Balogh, L, Thuróczy, J, Chen, J-C, Gerling, IC, Nam, S, Lim, J-S, Martínez-Ibañez, J, Real, J, Paschke, S, Quillet, R, Ayachi, S, Simonin, F, Schneider, EM, Brinkman, JA, Lamming, DW, Seroogy, CM, Röszer, T. Neuropeptide-FF increases M2 activation and self-renewal of adipose tissue macrophages. J Clin Investigation 2017.
  • Schneider, EM, Zielberg, D, Aigner, KR, Mostafa, H, Schneider, JM, Paschke, S. Systemic inflammation and immune suppression biomarkers in patients with solid tumors undergoing regional chemotherapy. Deutsche Zeitschrift für Onkologie Deutsche Zeitschrift für Onkologie 2017; 49: 8–14; DOI
  • Sander, S, Mostafa, H, Soboh, A, Schneider JM, Pala, A, Baron, A-K, Moepps, B, Wirtz, CR, Georgieff, M, Schneider, EM. Vacquinol-1 inducible cell death in glioblastoma multiforme is counter regulated by TRPM7 activity induced by exogenous ATP. ONCOTARGET, 2017
  • Mostafa, H, Pala, A., Hoegel, J, Hlavac, M, Dietrich, E, Westhoff, AM, Nonnenmacher, L, Burster, T, Georgieff, M, Wirtz, CR, Schneider, EM. Immune phenotypes predict survival in patients with glioblastoma multiforme. J Hematol Oncol. 2016; Sep 1;9(1):77. doi: 10.1186/s13045-016-0272-3.
  • Zirafi, O, Kyeong-Ae ,K., Ständker, L,  Mohr, K, Sauter, D, Heigele, A, Kluge, SF,  Wiercinska, E, Chudziak, D, Richter, R, Moepps, B, Gierschik, P, Vas, V, Geiger, H, Lamla, M, Weil, T, Burster, T, Zgraja, A., Daubeuf, F,  Frossard, N, Hachet-Haas, M, Heunisch, F, Reichetzeder, C,  Galzi, J-L, Pérez-Castell, J,  Angeles Canales-Mayordomo, P, Jiménez-Barbero, J,  Giménez-Gallego, G, Schneider, EM, et al. Discovery and characterization of an endogenous CXCR4 antagonist. Cell Reports 2015; 11:1-11.
  • Vashist, S.K., Marion Schneider, E., Lam, E., Hrapovic, S., and Luong, J.H. One-step antibody immobilization-based rapid and highly-sensitive sandwich ELISA procedure for potential in vitro diagnostics. Scientific reports 2014; 4, 4407.
  • Vashist, S.K., Schneider, EM, Zengerle, R., von Stetten, F., and Luong, J.H. Graphene-based rapid and highly-sensitive immunoassay for C-reactive protein using a smartphone-based colorimetric reader. Biosensors & bioelectronics 2014; 66C, 169-176.
  • Vashist, S.K., Mudanyali, O., Schneider, E.M., Zengerle, R., and Ozcan, A. Cellphone-based devices for bioanalytical sciences. Analytical and bioanalytical chemistry 2014; 406, 3263-3277.
  • Vashist, S.K., Schneider, E.M., and Luong, J.H. Surface plasmon resonance-based immunoassay for human fetuin A. The Analyst 2014; 139, 2237-2242.
  • Schmid, S., Schneider, EM., Brier, E.,Bäuerle, P. (2014) Self-organizing Carbohydrate-Oligothiophene-Hybrids for Eukaryotic Membrane-labelling. J. Mater. Chem. B, 2014, DOI: 10.1039/C4TB01472C.
  • Maxeiner HG, Marion Schneider E, Kurfiss ST, Brettschneider J, Tumani H, Bechter K. Cerebrospinal fluid and serum cytokine profiling to detect immune control of infectious and inflammatory neurological and psychiatric diseases. Cytokine 2014. 69:62-7.